ClinicalTrials.Veeva

Menu

Upper GI Outcomes Following EMR (UGI-EMR)

P

Professor Michael Bourke

Status

Completed

Conditions

Adenoma, Villous

Treatments

Procedure: Endoscopic Mucosal Resection

Study type

Observational

Funder types

Other

Identifiers

NCT02305290
HREC2014/7/4.6 (4033)

Details and patient eligibility

About

The purpose of this study is to evaluate the long-term outcomes of Endoscopic Resection (ER) of superficial lesions of the Upper Gastrointestinal Tract(UGIT)

Full description

Endoscopic resection (ER) of superficial lesions of the upper gastrointestinal tract is a safe and effective surgery-sparing modality in experienced hands. It is often curative of dysplastic lesions and is associated with minimal complications and high patient acceptance (1-5). Westmead Hospital has accumulated a significant amount of experience in the removal of such lesions; however, there is limited research to document the long term outcomes of patients undergoing endoscopic resection.The purpose of this study is to evaluate the long-term outcomes of ER of superficial lesions of the UGIT.

Enrollment

200 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • UGIT lesion > 10mm
  • Lesion limited to the mucosal and/or submucosal layer (T1 lesion)
  • Aged 18 years or older

Exclusion criteria

  • Lesion less than 10mm
  • Gastric lesion involves the muscularis propria (T2 lesion) on other staging modalities such as endoscopic ultrasonography (EUS)
  • Aged younger than 18 years

Trial design

200 participants in 1 patient group

Endoscopic Mucosal Resection
Description:
Patients who are referred for Endoscopic Mucosal Resection of Upper Gastrointestinal Lesions will be included in this cohort.
Treatment:
Procedure: Endoscopic Mucosal Resection

Trial contacts and locations

1

Loading...

Central trial contact

Rebecca Sonson, BN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems